Pawel Marcin Wisniewski
Direktor/Vorstandsmitglied bei PURE BIOLOGICS S.A.
Profil
Pawel Marcin Wisniewski is currently serving as the Vice Chairman-Management Board at Helix Immuno-Oncology SA. He is also the Deputy Chairman-Supervisory Board at Pure Biologics SA and the Vice President-Management Board at 4cell Therapies SA. Previously, he held the position of Chief Executive Officer at Helix Polska Sp zoo and worked as a Project Manager at Adiuvo Investments SA from 2012 to 2016.
Aktive Positionen von Pawel Marcin Wisniewski
Unternehmen | Position | Beginn |
---|---|---|
PURE BIOLOGICS S.A. | Direktor/Vorstandsmitglied | 26.05.2023 |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Pawel Marcin Wisniewski
Unternehmen | Position | Ende |
---|---|---|
Helix Polska Sp zoo
Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PURE BIOLOGICS S.A. | Health Technology |
Private Unternehmen | 2 |
---|---|
Helix Polska Sp zoo
Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Health Technology |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |